This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Argenx Iip Bv, New York University. Active years: 2022.
Company Filing History:
1 out of 2 
1 out of 1,726 
Years Active: 2022
Title: Innovations of Julien Oury in Therapeutic Antibodies
Introduction
Julien Oury is a notable inventor based in New York, NY (US). He has made significant contributions to the field of therapeutic antibodies, particularly in the treatment of neuromuscular conditions. His innovative work has garnered attention in the scientific community.
Latest Patents
Julien Oury holds a patent for "Therapeutic musk antibodies." This invention relates to antibody-based molecules, including full-length antibodies, antigen-binding domains, and antibody derivatives that can bind to and activate human muscle-specific tyrosine protein kinase (MuSK). The patent also discloses methods for treating neuromuscular conditions using these MuSK antibodies. He has 1 patent to his name.
Career Highlights
Throughout his career, Julien Oury has worked with prestigious institutions, including New York University and Argenx IP BV. His research has focused on advancing therapeutic options for patients suffering from neuromuscular disorders.
Collaborations
Julien has collaborated with esteemed colleagues such as Steven J. Burden and Shohei Koide. These partnerships have contributed to the development and refinement of his innovative therapeutic approaches.
Conclusion
Julien Oury's work in therapeutic antibodies represents a significant advancement in the treatment of neuromuscular conditions. His contributions continue to impact the field positively.